A detailed history of Compagnie Lombard Odier S Cm A transactions in Merck & Co., Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 1,474,544 shares of MRK stock, worth $147 Million. This represents 2.74% of its overall portfolio holdings.

Number of Shares
1,474,544
Previous 968,914 52.19%
Holding current value
$147 Million
Previous $120 Million 39.6%
% of portfolio
2.74%
Previous 2.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$111.15 - $128.97 $56.2 Million - $65.2 Million
505,630 Added 52.19%
1,474,544 $167 Million
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $12.9 Million - $13.8 Million
104,006 Added 12.03%
968,914 $120 Million
Q1 2024

May 01, 2024

BUY
$113.24 - $131.95 $18.7 Million - $21.8 Million
165,131 Added 23.6%
864,908 $114 Million
Q4 2023

Jan 16, 2024

BUY
$100.18 - $109.02 $6.37 Million - $6.93 Million
63,591 Added 10.0%
699,777 $76.3 Million
Q3 2023

Oct 23, 2023

BUY
$102.95 - $114.33 $4.14 Million - $4.6 Million
40,212 Added 6.75%
636,186 $65.5 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $2.44 Million - $2.66 Million
-22,460 Reduced 3.63%
595,974 $68.8 Million
Q1 2023

May 01, 2023

SELL
$102.94 - $114.86 $11.4 Million - $12.7 Million
-110,948 Reduced 15.21%
618,434 $65.8 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $3.58 Million - $4.59 Million
40,974 Added 5.95%
729,382 $80.9 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $5.11 Million - $5.74 Million
-60,471 Reduced 8.07%
688,408 $59.3 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $883,825 - $1 Million
-10,586 Reduced 1.39%
748,879 $68.3 Million
Q1 2022

Apr 27, 2022

SELL
$73.51 - $82.4 $217,369 - $243,656
-2,957 Reduced 0.39%
759,465 $62.3 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $2.35 Million - $2.95 Million
-32,538 Reduced 4.09%
762,422 $58.4 Million
Q3 2021

Oct 28, 2021

SELL
$71.68 - $78.83 $1.89 Million - $2.08 Million
-26,397 Reduced 3.21%
794,960 $59.7 Million
Q2 2021

Jul 15, 2021

SELL
$70.31 - $77.77 $1.93 Million - $2.13 Million
-27,404 Reduced 3.23%
821,357 $63.9 Million
Q1 2021

Apr 23, 2021

BUY
$68.86 - $81.11 $5.83 Million - $6.87 Million
84,660 Added 11.08%
848,761 $65.4 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $678,011 - $752,453
9,447 Added 1.25%
764,101 $62.5 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $8.06 Million - $9.14 Million
110,185 Added 17.1%
754,654 $62.6 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $5.04 Million - $5.73 Million
71,549 Added 12.49%
644,469 $49.8 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $1.76 Million - $2.44 Million
27,743 Added 5.09%
572,920 $44.1 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $4 Million - $4.51 Million
51,539 Added 10.44%
545,177 $49.6 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $6.87 Million - $7.49 Million
90,273 Added 22.38%
493,638 $41.6 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $583,722 - $681,929
-8,358 Reduced 2.03%
403,365 $33.8 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $396,397 - $452,113
5,697 Added 1.4%
411,723 $34.2 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $1.03 Million - $1.2 Million
-15,808 Reduced 3.75%
406,026 $31 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $993,133 - $1.17 Million
-17,215 Reduced 3.92%
421,834 $29.9 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $1.1 Million - $1.29 Million
21,577 Added 5.17%
439,049 $26.7 Million
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $668,289 - $776,742
-13,114 Reduced 3.05%
417,472 $22.7 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $929,882 - $1.11 Million
-18,014 Reduced 4.02%
430,586 $24.2 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $6.15 Million - $6.62 Million
-104,798 Reduced 18.94%
448,600 $28.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
553,398
553,398 $35.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.